These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 27564662

  • 21. Proteinase 3 activity in sputum from subjects with alpha-1-antitrypsin deficiency and COPD.
    Sinden NJ, Stockley RA.
    Eur Respir J; 2013 May; 41(5):1042-50. PubMed ID: 22936713
    [Abstract] [Full Text] [Related]

  • 22. [Lack of effect of substitution therapy of alpha1-antitrypsin deficiency].
    Dahl R, Hilberg O, Løkke A, Pedersen L, Ringbæk T, Titlestad I.
    Ugeskr Laeger; 2011 Oct 17; 173(42):2645-7. PubMed ID: 22027165
    [Abstract] [Full Text] [Related]

  • 23. Efficacy of augmentation therapy for emphysema associated with α1-antitrypsin deficiency: enough is enough.
    Balbi B, Ferrarotti I, Miravitlles M.
    Eur Respir J; 2016 Jan 17; 47(1):35-8. PubMed ID: 26721962
    [No Abstract] [Full Text] [Related]

  • 24. [Analysis of alpha-1-antitrypsin phenotypes and genotypes in patients with early-onset pulmonary emphysema].
    Dwomiczak S, Ziora D, Konofalski L, Szalaty M, Kowalska A, Kozielski J.
    Pneumonol Alergol Pol; 2005 Jan 17; 73(1):12-7. PubMed ID: 16539178
    [Abstract] [Full Text] [Related]

  • 25. The proteinase-antiproteinase theory of emphysema: a speculative analysis of recent advances into the pathogenesis of emphysema.
    Knight KR, Burdon JG, Cook L, Brenton S, Ayad M, Janus ED.
    Respirology; 1997 Jun 17; 2(2):91-5. PubMed ID: 9441132
    [Abstract] [Full Text] [Related]

  • 26. Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications.
    Chapman KR, Chorostowska-Wynimko J, Koczulla AR, Ferrarotti I, McElvaney NG.
    Int J Chron Obstruct Pulmon Dis; 2018 Jun 17; 13():419-432. PubMed ID: 29430176
    [Abstract] [Full Text] [Related]

  • 27. Alpha 1-antitrypsin-deficiency-related emphysema.
    Barker AF.
    J Am Board Fam Pract; 1992 Jun 17; 5(5):489-93. PubMed ID: 1414450
    [Abstract] [Full Text] [Related]

  • 28. Deletion of Serpina1a, a murine α1-antitrypsin ortholog, results in embryonic lethality.
    Wang D, Wang W, Dawkins P, Paterson T, Kalsheker N, Sallenave JM, Houghton AM.
    Exp Lung Res; 2011 Jun 17; 37(5):291-300. PubMed ID: 21574874
    [Abstract] [Full Text] [Related]

  • 29. Effect of cigarette smoke exposure and structural modifications on the α-1 Antitrypsin interaction with caspases.
    Lockett AD, Van Demark M, Gu Y, Schweitzer KS, Sigua N, Kamocki K, Fijalkowska I, Garrison J, Fisher AJ, Serban K, Wise RA, Flotte TR, Mueller C, Presson RG, Petrache HI, Tuder RM, Petrache I.
    Mol Med; 2012 May 09; 18(1):445-54. PubMed ID: 22245800
    [Abstract] [Full Text] [Related]

  • 30. Acute-phase protein α1-antitrypsin--a novel regulator of angiopoietin-like protein 4 transcription and secretion.
    Frenzel E, Wrenger S, Immenschuh S, Koczulla R, Mahadeva R, Deeg HJ, Dinarello CA, Welte T, Marcondes AM, Janciauskiene S.
    J Immunol; 2014 Jun 01; 192(11):5354-62. PubMed ID: 24760148
    [Abstract] [Full Text] [Related]

  • 31. Anti-Proteases and Alpha-1 Antitrypsin Augmentation Therapy.
    Strange C.
    Respir Care; 2018 Jun 01; 63(6):690-698. PubMed ID: 29794204
    [Abstract] [Full Text] [Related]

  • 32. α1-Antitrypsin activates protein phosphatase 2A to counter lung inflammatory responses.
    Geraghty P, Eden E, Pillai M, Campos M, McElvaney NG, Foronjy RF.
    Am J Respir Crit Care Med; 2014 Dec 01; 190(11):1229-42. PubMed ID: 25341065
    [Abstract] [Full Text] [Related]

  • 33. Alpha-1-antitrypsin is produced by human neutrophil granulocytes and their precursors and liberated during granule exocytosis.
    Clemmensen SN, Jacobsen LC, Rørvig S, Askaa B, Christenson K, Iversen M, Jørgensen MH, Larsen MT, van Deurs B, Ostergaard O, Heegaard NH, Cowland JB, Borregaard N.
    Eur J Haematol; 2011 Jun 01; 86(6):517-30. PubMed ID: 21477074
    [Abstract] [Full Text] [Related]

  • 34. Neutrophil elastase-mediated lung disease.
    Sandhaus RA, Turino G.
    COPD; 2013 Mar 01; 10 Suppl 1():60-3. PubMed ID: 23527919
    [Abstract] [Full Text] [Related]

  • 35. Recent advances in α-1-antitrypsin deficiency-related lung disease.
    Brebner JA, Stockley RA.
    Expert Rev Respir Med; 2013 Jun 01; 7(3):213-29; quiz 230. PubMed ID: 23734645
    [Abstract] [Full Text] [Related]

  • 36. Alpha-1 Antitrypsin Therapy in Cystic Fibrosis and the Lung Disease Associated with Alpha-1 Antitrypsin Deficiency.
    McElvaney NG.
    Ann Am Thorac Soc; 2016 Apr 01; 13 Suppl 2():S191-6. PubMed ID: 27115956
    [Abstract] [Full Text] [Related]

  • 37. Biomarkers in Alpha-1 Antitrypsin Deficiency Chronic Obstructive Pulmonary Disease.
    Turino GM, Ma S, Cantor JO, Lin YY.
    Ann Am Thorac Soc; 2016 Aug 01; 13 Suppl 4():S336-40. PubMed ID: 27564670
    [Abstract] [Full Text] [Related]

  • 38. Secretory leukocyte proteinase inhibitor, alpha-1-antitrypsin deficiency and emphysema: Preliminary study, speculation and an hypothesis.
    Ayad MS, Knight KR, Burdon JG, Brenton S.
    Respirology; 2003 Jun 01; 8(2):175-80. PubMed ID: 12753532
    [Abstract] [Full Text] [Related]

  • 39. Emerging drugs for alpha-1-antitrypsin deficiency.
    Stockley RA.
    Expert Opin Emerg Drugs; 2010 Dec 01; 15(4):685-94. PubMed ID: 20716026
    [Abstract] [Full Text] [Related]

  • 40. Alpha-1-antitrypsin deficiency: current concepts.
    Mulgrew AT, Taggart CC, McElvaney NG.
    Lung; 2007 Dec 01; 185(4):191-201. PubMed ID: 17562108
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.